Fennec Pharmaceuticals Q3 EPS $(0.09) Up From $(0.14) YoY

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.09) per share. This is a 35.71 percent increase over losses of $(0.14) per share from the same period last year.

Benzinga · 11/12/2019 11:07

Fennec Pharmaceuticals (NASDAQ:FENC) reported quarterly losses of $(0.09) per share. This is a 35.71 percent increase over losses of $(0.14) per share from the same period last year.